Skip to content

uniQure QURE Gross Profit

Gross Profit at other companies

ALN
Alnylam PharmaceuticalsALNY
$959.66M+83.1%
Amgen logo
AmgenAMGN
$5.87B+13.4%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$151.04M+7.1%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$19.43M+154%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
TG Therapeutics logo
TG TherapeuticsTGTX

Other financials

Income statement

See full
Revenue$3.6M+127%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Calculated from uniQure’s reported figures.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's gross profit?
uniQure (QURE) reported gross profit of $3.34M in Q1 2026.
How has uniQure's gross profit changed year-over-year?
uniQure's gross profit increased by 144.0% year-over-year, from $1.37M to $3.34M.
What is the long-term trend for uniQure's gross profit?
Over 4 years (2021 to 2025), uniQure's gross profit has grown at a -58.8% compound annual growth rate (CAGR), from $499.03M to $14.41M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.